Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF: ONCO3)
Brazil
· Delayed Price · Currency is BRL 5.92
+0.49 (9.04%)
Sep 11, 2024, 4:41 PM GMT-3
ONCO3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 5,862 | 5,489 | 4,088 | 2,702 | 2,035 | 1,690 | Upgrade
|
| Revenue Growth (YoY) | 16.46% | 34.26% | 51.30% | 32.77% | 20.46% | 60.78% | Upgrade
|
| Cost of Revenue | 3,870 | 3,560 | 2,636 | 1,833 | 1,400 | 1,086 | Upgrade
|
| Gross Profit | 1,992 | 1,929 | 1,452 | 868.79 | 635.68 | 603.12 | Upgrade
|
| Selling, General & Admin | 1,241 | 1,172 | 980.82 | 688.05 | 603.61 | 483.32 | Upgrade
|
| Other Operating Expenses | -4.53 | -13.16 | 0.19 | 3.53 | 12.45 | -1.95 | Upgrade
|
| Operating Expenses | 1,236 | 1,159 | 981.01 | 691.58 | 616.06 | 481.37 | Upgrade
|
| Operating Income | 755.63 | 769.67 | 471.1 | 177.22 | 19.62 | 121.76 | Upgrade
|
| Interest Expense | -579.27 | -559.79 | -396.47 | -154.36 | -94.8 | -41.61 | Upgrade
|
| Interest & Investment Income | 81.49 | 101.98 | 128.84 | 54.41 | 21.93 | 10.45 | Upgrade
|
| Earnings From Equity Investments | -11.94 | -11.65 | -0.54 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -19.22 | 7.92 | 8.52 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -45.62 | 8.82 | -75.79 | -10.98 | - | -10.23 | Upgrade
|
| EBT Excluding Unusual Items | 181.06 | 316.95 | 135.67 | 66.29 | -53.26 | 80.37 | Upgrade
|
| Legal Settlements | -13.21 | -14.43 | -14.13 | -3.95 | - | - | Upgrade
|
| Pretax Income | 167.84 | 302.52 | 121.54 | 62.34 | -53.26 | 80.37 | Upgrade
|
| Income Tax Expense | -107.18 | -10.04 | 7.77 | 84.75 | 68.09 | 61.27 | Upgrade
|
| Earnings From Continuing Operations | 275.02 | 312.56 | 113.77 | -22.42 | -121.34 | 19.1 | Upgrade
|
| Minority Interest in Earnings | -81.7 | -88.94 | -67.51 | -24.48 | -36.35 | -39.51 | Upgrade
|
| Net Income | 193.32 | 223.62 | 46.26 | -46.9 | -157.69 | -20.42 | Upgrade
|
| Net Income to Common | 193.32 | 223.62 | 46.26 | -46.9 | -157.69 | -20.42 | Upgrade
|
| Net Income Growth | 33.20% | 383.39% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 551 | 524 | 480 | 412 | 402 | 401 | Upgrade
|
| Shares Outstanding (Diluted) | 563 | 536 | 532 | 412 | 402 | 401 | Upgrade
|
| Shares Change (YoY) | 1.05% | 0.72% | 28.93% | 2.65% | 0.29% | -98.83% | Upgrade
|
| EPS (Basic) | 0.35 | 0.43 | 0.10 | -0.11 | -0.39 | -0.05 | Upgrade
|
| EPS (Diluted) | 0.34 | 0.42 | 0.09 | -0.11 | -0.39 | -0.05 | Upgrade
|
| EPS Growth | 31.82% | 379.95% | - | - | - | - | Upgrade
|
| Free Cash Flow | -614.09 | -363.26 | -571.82 | -211.23 | -19.24 | -93.12 | Upgrade
|
| Free Cash Flow Per Share | -1.09 | -0.68 | -1.08 | -0.51 | -0.05 | -0.23 | Upgrade
|
| Gross Margin | 33.98% | 35.14% | 35.52% | 32.15% | 31.23% | 35.70% | Upgrade
|
| Operating Margin | 12.89% | 14.02% | 11.52% | 6.56% | 0.96% | 7.21% | Upgrade
|
| Profit Margin | 3.30% | 4.07% | 1.13% | -1.74% | -7.75% | -1.21% | Upgrade
|
| Free Cash Flow Margin | -10.48% | -6.62% | -13.99% | -7.82% | -0.95% | -5.51% | Upgrade
|
| EBITDA | 916.58 | 931.27 | 586.27 | 270.2 | 126.43 | 158.74 | Upgrade
|
| EBITDA Margin | 15.64% | 16.97% | 14.34% | 10.00% | 6.21% | 9.40% | Upgrade
|
| D&A For EBITDA | 160.96 | 161.6 | 115.17 | 92.99 | 106.81 | 36.99 | Upgrade
|
| EBIT | 755.63 | 769.67 | 471.1 | 177.22 | 19.62 | 121.76 | Upgrade
|
| EBIT Margin | 12.89% | 14.02% | 11.52% | 6.56% | 0.96% | 7.21% | Upgrade
|
| Effective Tax Rate | - | - | 6.39% | 135.96% | - | 76.24% | Upgrade
|
| Revenue as Reported | 373.31 | - | - | 2,702 | 2,035 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.